Literature DB >> 5337570

The biology and pathology of the initial stages of blood coagulation.

O D Ratnoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5337570

Source DB:  PubMed          Journal:  Prog Hematol        ISSN: 0079-6301


× No keyword cloud information.
  18 in total

1.  Partial purification and characterization of contact activation cofactor.

Authors:  S Schiffman; P Lee
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

2.  Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

3.  Generation of the bioactive kallikrein-derived fragment, C3d-k, by HANE-plasma.

Authors:  T Seya; S Nagasawa; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

Review 4.  Local and systemic factors in the pathogenesis of thrombosis.

Authors:  D Deykin
Journal:  Calif Med       Date:  1970-03

5.  Mechanism of activation of coagulation factor XI by factor XIIa studied with monoclonal antibodies.

Authors:  H Akiyama; D Sinha; F S Seaman; E P Kirby; P N Walsh
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

6.  Factors XI and XII are low in subjects with liver disease.

Authors:  I R Walker; R A Milner; M A Johnston; C A Rand; P B Neame; J Hirsh
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

7.  Inflammatory sequences in acute pulmonary radiation injury.

Authors:  D O Slauson; F F Hahn; S A Benjamin; T L Chiffelle; R K Jones
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

8.  Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

9.  Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.

Authors:  H Saito; O D Ratnoff; J S Marshall; J Pensky
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

10.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.